近年来，随着肿瘤治疗中药物丰富度的增加，靶向治疗药物、免疫治疗药物的覆盖面和适用人群逐步从辅助治疗到新辅助治疗。药物治疗过程中难免出现副反应，而肿瘤治疗相关性肺炎则是其中并不罕见的一类。近期，中华医学会呼吸病学年会（CTS ...

The test, done at Poole Hospital, identified two key genes driving her cancer, ALK fusion and TP53, and doctors prescribed brigatinib, a drug that targets the ALK gene. “Having the ctDNA test results ...

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today ...

A little over a decade later, my mom was diagnosed with lung cancer, and her prognosis was just as dire. We would later find ...

GUANGZHOU, China, Oct. 10, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: BNR, the “Company” or “Burning Rock”), an innovative company in ...

By blocking IL-22 in keratinocytes, temtokibart normalizes the skin barrier and boosts hydration, suggested a study of gene ...

Researchers hope DeepGEM can expedite targeted treatment for lung cancer patients who can't access standard genomic testing.

The FDA granted traditional approval to selpercatinib for the treatment of advanced or metastatic RET-mutated medullary ...

Actor Chris Hemsworth knows it. He watched his grandfather live with Alzheimer’s and is making lifestyle changes after learning he has two copies of the APOE4 gene. This gene is a risk factor for ...

Detailed price information for Castle Biosciences Inc (CSTL-Q) from The Globe and Mail including charting and trades.

The EU has banned animal testing for cosmetics and non-animal alternative methods are preferable for the risk assessment of ...

A high density of tumor-associated macrophages (TAMs) is associated with poorer prognosis and survival in breast cancer patients. Recent studies have shown that lipid accumulation in TAMs can promote ...